Acrotech Biopharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Beleodaq | Belinostat | 2014-07-03 | 2026-2027 | |
| Evomela | Melphalan | 2016-03-10 | 2029-2036 | |
| Folotyn | Pralatrexate | 2009-09-24 | 2025 | |
| Fusilev | Levoleucovorin | 2008-03-07 | 2039 | — |
| Khapzory | Levoleucovorin | 2018-10-19 | 2039 | — |
| Marqibo | Vincristine | 2012-08-09 | ||
| Zevalin | Ibritumomab tiuxetan | 2002-02-19 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use